Preparation and characterization of intestine PepT1-targeted calcium carbonate nanoparticles

doi:10.5246/jcps.2018.06.040

Abstract

Abstract:

To improve the oral absorption of poorly water-soluble drugs by overcoming the intestinal epithelium barrier, calcium carbonate nanoparticles targeting to intestine peptide transporter 1 (PepT1) were fabricated by modification of the surface of calcium carbonate nanoparticles with Gly-Sar. Gly-Sar-conjugated TPGS was successfully synthesized and characterized, and coumarin 6-loaded Gly-Sar modified calcium carbonate nanoparticles were then prepared and characterized to have a nano-scaledsize of about 193 nm in diameter, cracked surface morphology under a scanning electron microscope, and high drug loading efficiency (60.5±5.9)%. Moreover, the Gly-Sar-modified calcium carbonate nanoparticles exhibited better drug loading stability during the process of their transcellular transport, and evidently enhanced intestinal absorption of poorly water-soluble agents. Therefore, the designed intestine PepT1-targeted calcium carbonate nanoparticles might have a promising potential for oral delivery of poorly water-soluble drugs.

Key words: Calcium carbonate nanoparticles, Oligopeptide transporter, Gly-Sar, In vitro release, Intestinal absorption

CLC Number:

R944

Supporting:

Yunqiang Deng, Yao Jin, Chuyu He, Yang Zou, Yuanhang Zhou, Shidi Han, Chuhang Zhou, Qi Liu, Xinru Li, Yanxia Zhou, Yan Liu . Preparation and characterization of intestine PepT1-targeted calcium carbonate nanoparticles[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(6): 397-407.

References

[1] Plapied, L.; Duhem, N.; des Rieux, A.; Preat, V. Fate of Polymeric Nanocarriers for Oral Drug Delivery. Curr. Opin. Colloid. In. 2011, 16, 228-237.

[2] Takagi, T.; Ramachandran, C.; Bermejo, M.; Yamashita, S.; Yu, L.X.; Amidon, G.L. A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan. Mol. Pharm. 2006, 3, 631-643.

[3] Fakayode, O.J.; Tsolekile, N.; Songca, S.P.; Oluwafemi, O.S. Applications of Functionalized Nanomaterials in Photodynamic Therapy. Biophys. Rev. 2018.

[4] Zhou, Y.; Peng, Z.; Seven, E.S.; Leblanc, R.M. Crossing the Blood-Brain Barrier with Nanoparticles. J. Controlled Release. 2017, 270, 290-303.

[5] Gujarathi, N.A.; Rane, B.R.; Patel, J.K. Ph Sensitive Polyelectrolyte Complex of O-Carboxymethyl Chitosan and Poly (Acrylic Acid) Cross-Linked with Calcium for Sustained Delivery of Acid Susceptible Drugs. Int. J. Pharm. 2012, 436, 418-425.

[6] Tang, H.; Zheng, Y.; Chen, Y. Materials Chemistry of Nanoultrasonic Biomedicine. Adv. Mater. 2017, 29, 1-22.

[7] Ray, P.C.; Yu, H.; Fu, P.P. Toxicity and Environmental Risks of Nanomaterials: Challenges and Future Needs. J. Environ. Sci. Health C. 2009, 27, 1-35.

[8] Kamba, A.S.; Ismail, M.; Ibrahim, T.A.; Zakaria, Z.A. Biocompatibility of Bio Based Calcium Carbonate Nanocrystals Aragonite Polymorph on Nih 3t3 Fibroblast Cell Line. Afr. J. Tradit. Complement. Altern. Med. 2014, 11, 31-38.

[9] Varma, M.V.; Ambler, C.M.; Ullah, M.; Rotter, C.J.; Sun, H.; Litchfield, J.; Fenner, K.S.; El-Kattan, A.F. Targeting Intestinal Transporters for Optimizing Oral Drug Absorption. Curr. Drug Metab. 2010, 11, 730-742.

[10] Incecayir, T.; Sun, J.; Tsume, Y.; Xu, H.; Gose, T.; Nakanishi, T.; Tamai, I.; Hilfinger, J.; Lipka, E.; Amidon, G.L. Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue. J. Pharm. Sci. 2016, 105, 925-934.

[11] Putnam, W.S.; Pan, L.; Tsutsui, K.; Takahashi, L.; Benet, L.Z. Comparison of Bidirectional Cephalexin Transport across Mdck and Caco-2 Cell Monolayers: Interactions with Peptide Transporters. Pharm. Res. 2002, 19, 27-33.

[12] Newstead, S.; Drew, D.; Cameron, A.D.; Postis, V.L.G.; Xia, X.B.; Fowler, P.W.; Ingram, J.C.; Carpenter, E.P.; Sansom, M.S.P.; McPherson, M.J.; Baldwin, S.A.; Iwata, S. Crystal Structure of a Prokaryotic Homologue of the Mammalian Oligopeptide-Proton Symporters, Pept1 and Pept2. EMBO J. 2011, 30, 417-426.

[13] Vig, B.S.; Huttunen, K.M.; Laine, K.; Rautio, J. Amino Acids as Promoieties in Prodrug Design and Development. Adv. Drug Deliv. Rev. 2013, 65, 1370-1385.

[14] Wang, H.P.; Wang, C.L. Biological Transporters as Targets for New Drug Design. J. Exp. Clin. Med. 2009, 1, 31-38.

[15] Beauchamp, L.M.; Orr, G.F.; Demiranda, P.; Burnette, T.; Krenitsky, T.A. Amino-Acid Ester Prodrugs of Acyclovir. Antivir. Chem. Chemoth. 1992, 3, 157-164.

[16] Alteheld, B.; Evans, M.E.; Gu, L.H.; Ganapathy, V.; Leibach, F.H.; Jones, D.P.; Ziegler, T.R. Alanylglutamine Dipeptide and Growth Hormone Maintain Pept1-Mediated Transport in Oxidatively Stressed Caco-2 Cells. J. Nutr. 2005, 135, 19-26.

[17] Wu, J.L.; Wang, C.Q.; Zhuo, R.X.; Cheng, S.X. Multi-Drug Delivery System Based on Alginate/Calcium Carbonate Hybrid Nanoparticles for Combination Chemotherapy. Colloids. Sur. B, Biointerfaces. 2014, 123, 498-505.

[18] Preisig, D.; Haid, D.; Varum, F.J.O.; Bravo, R.; Alles, R.; Huwyler, J.; Puchkov, M. Drug Loading into Porous Calcium Carbonate Microparticles by Solvent Evaporation. Eur. J. Pharm. Biopharm. 2014, 87, 548-558.

[19] Wang, X.; Li, X.; Li, Y.; Zhou, Y.; Fan, C.; Li, W.; Ma, S.; Fan, Y.; Huang, Y.; Li, N.; Liu, Y. Synthesis, Characterization and Biocompatibility of Poly(2-Ethyl-2-Oxazoline)-Poly(D,L-Lactide)-Poly(2-Ethyl-2-Oxazoline) Hydrogels. Acta Biomaterialia. 2011, 7, 4149-4159.

[20] Gao, Y.J.; Li, Y.F.; Li, Y.S.; Yuan, L.; Zhou, Y.X.; Li, J.W.; Zhao, L.; Zhang, C.; Li, X.R.; Liu, Y. Psma-Mediated Endosome Escape-Accelerating Polymeric Micelles for Targeted Therapy of Prostate Cancer and the Real Time Tracing of Their Intracellular Trafficking. Nanoscale. 2015, 7, 597-612.

[21] Wang, D.; Zhou, Y.; Li, X.; Qu, X.; Deng, Y.; Wang, Z.; He, C.; Zou, Y.; Jin, Y.; Liu, Y. Mechanisms of Ph-Sensitivity and Cellular Internalization of Peoz-B-Pla Micelles with Varied Hydrophilic/Hydrophobic Ratios and Intracellular Trafficking Routes and Fate of the Copolymer. ACS Appl. Mater. Int. 2017, 9, 6916-6930.

[22] Nagamuthu, S.; Vijayakumar, S.; Muralidharan, G. Synthesis of Mn3o4/Amorphous Carbon Nanoparticles as Electrode Material for High Performance Supercapacitor Applications. Energy. Fuels. 2013, 27, 3508-3515.

[23] Ni, J.; Tian, F.; Dahmani, F.Z.; Yang, H.; Yue, D.; He, S.; Zhou, J.; Yao, J. Curcumin-Carboxymethyl Chitosan (Cnc) Conjugate and Cnc/Lhr Mixed Polymeric Micelles as New Approaches to Improve the Oral Absorption of P-Gp Substrate Drugs. Drug Deliv. 2016, 23, 3424-3435.

[24] Li, J.F.; Xu, Z.L.; Yang, H.; Yu, L.Y.; Liu, M. Effect of Tio2 Nanoparticles on the Surface Morphology and Performance of Microporous Pes Membrane. Appl. Surf. Sci. 2009, 255, 4725-4732.

[25] Bang, J.H.; Jang, Y.N.; Kim, W.; Song, K.S.; Jeon, C.W.; Chae, S.C.; Lee, S.W.; Park, S.J.; Lee, M.G. Specific Surface Area and Particle Size of Calcium Carbonate Precipitated by Carbon Dioxide Microbubbles. Chem. Eng. J. 2012, 198, 254-260.

[26] Yang, T. Z.; Wan, Z. H.; Liu, Z. Y.; Li, H. H.; Wang, H.; Lu, N.; Chen, Z. H.; Mei, X. F.; Ren, X. L. In Situ Mineralization of Anticancer Drug into Calcium Carbonate Monodisperse Nanospheres and Their Ph-Responsive Release Property. Mat. Sci. Eng. C. 2016, 63, 384-392.
[27] Gourdon, B.; Chemin, C.; Moreau, A.; Arnauld, T.; Baumy, P.; Cisternino, S.; Pean, J.M.; Decleves, X. Functionalized Pla-Peg Nanoparticles Targeting Intestinal Transporter Pept1 for Oral Delivery of Acyclovir. Int. J. Pharm. 2017, 529, 357-370.